Skip to main content

Dosist debuts topical line

The line of dosist health CBD+ products includes a lotion, a roll-on and a spray. 
salazar
indoor,thing,sitting,table,counter,computer,toothbrush,desk,lotion,different,brush,keyboard,remote,sink,mouse,bottle,laying,game,kitchen,group

CBD and wellness brand dosist is launching its dosist health brand with a lineup of topical products with CBD in three formats. The line of dosist health CBD+ products includes a lotion, a roll-on and a spray. 

"We spent the last 3 years developing topical analgesics formulated with precise measurements of cannabinoids and natural botanical ingredients in addition to sophisticated absorption technology to help mitigate pain and inflammation," said Jason DeLand, executive chairman and co-founder of dosist. "We believe that happiness is the highest form of health, and each product within our dosist health CBD+ category is thoughtfully and scientifically engineered to help people improve their quality of life."

The dosist Topical Performance Spray includes a proprietary nanoblend technology — which combines CBD and cannabigerol, or CBG, as well as cannabichromene, or CBC —meant to allow for rapid absorption. The product is designed with athletes in mind and contains capsicum, menthol and arnica alongside the cannabinoids. It contains 750 mg of cannabinoids per bottle and has a suggested retail price of $49.

The line’s Topical CBD Lotion and Topical CBD Roll-On each combine rations of CBD and CBG with active plant ingredients to offer a formula that can help relieve pain and inflammation. The Topical CBD Lotion — which contains 825 mg of cannabinoids per bottle, has a suggested retail price of $44.  The Topical CBD Roll-On has a suggested price of $38, with each roll-on 

"Cannabinoids, terpenes and natural phytochemicals are incredible natural conduits in helping many quality-of-life needs that modern consumers face," DeLand said.  "It is our mission to optimize these elements to unlock these needs through our scientific formulas, precision dosage and increased bioavailability, and we are thrilled to bring this platform to the topical pain relief category across the US today." 
 

Most Popular Content

Every Major Retail Media Network Can Prove Incrementality — And That's the Problem

Circana's Moody Khan explains the quiet tax on retail media's success and how it will earn the next wave of investment.

How Chewy Is Helping Brands Reach Pet Parents Earlier

For pet brands, it's important to educate shoppers who may not be actively browsing but may still be open to guidance when the right need emerges, according to the head of Chewy Ads.
Chewy

Why Retail Media Has Outgrown the CPG Org Chart

The next phase of success will belong to companies integrating multiple aspects of their business into a single strategy, writes Blue Chip's Sarah VanHeirseele.
Sarah VanHeirseele of agency Blue Chip

Inside Kellanova's Omnichannel Program With U.S. Soccer

The full-funnel effort includes retail media and in-store activations at Walmart, Costco and multiple grocers.
Kellanova and U.S. Soccer 2026 program at retail

Retail Media Summit 2026: What Comes Next for Retail Media

Seven signals are defining the future of commerce, media and the shopper experience. Read on for insights from leading brands, retailers, agencies and tech providers.
P2PI Retail Media Summit
X
This ad will auto-close in 10 seconds